45 related articles for article (PubMed ID: 1832998)
1. Genetically corrected RAG2-SCID human hematopoietic stem cells restore V(D)J-recombinase and rescue lymphoid deficiency.
Pavel-Dinu M; Gardner CL; Nakauchi Y; Kawai T; Delmonte OM; Palterer B; Bosticardo M; Pala F; Viel S; Malech HL; Ghanim HY; Bode NM; Kurgan GL; Detweiler AM; Vakulskas CA; Neff NF; Sheikali A; Menezes ST; Chrobok J; Hernández González EM; Majeti R; Notarangelo LD; Porteus MH
Blood Adv; 2024 Apr; 8(7):1820-1833. PubMed ID: 38096800
[TBL] [Abstract][Full Text] [Related]
2. Deletion of the RAG2 C terminus leads to impaired lymphoid development in mice.
Akamatsu Y; Monroe R; Dudley DD; Elkin SK; Gartner F; Talukder SR; Takahama Y; Alt FW; Bassing CH; Oettinger MA
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1209-14. PubMed ID: 12531919
[TBL] [Abstract][Full Text] [Related]
3. RAG suppresses group 2 innate lymphoid cells.
Ver Heul AM; Mack M; Zamidar L; Tamari M; Yang TL; Trier AM; Kim DH; Janzen-Meza H; Van Dyken SJ; Hsieh CS; Karo JM; Sun JC; Kim BS
bioRxiv; 2024 Apr; ():. PubMed ID: 38712036
[TBL] [Abstract][Full Text] [Related]
4. Evolutionary preservation of CpG dinucleotides in RAG1 may elucidate the relatively high rate of methylation-mediated mutagenesis of RAG1 transposase.
Fawzy MM; Nazmy MH; El-Sheikh AAK; Fathy M
Immunol Res; 2024 Jan; ():. PubMed ID: 38240953
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA, miR-501 regulate the V(D)J recombination in B cells.
Kumari R; Roy U; Desai S; Mondal AS; Nair RR; Nilavar N; Choudhary B; Raghavan SC
Biochem J; 2023 Dec; 480(24):2061-2077. PubMed ID: 38084601
[TBL] [Abstract][Full Text] [Related]
6. Characterization of T and B cell repertoire diversity in patients with RAG deficiency.
Lee YN; Frugoni F; Dobbs K; Tirosh I; Du L; Ververs FA; Ru H; Ott de Bruin L; Adeli M; Bleesing JH; Buchbinder D; Butte MJ; Cancrini C; Chen K; Choo S; Elfeky RA; Finocchi A; Fuleihan RL; Gennery AR; El-Ghoneimy DH; Henderson LA; Al-Herz W; Hossny E; Nelson RP; Pai SY; Patel NC; Reda SM; Soler-Palacin P; Somech R; Palma P; Wu H; Giliani S; Walter JE; Notarangelo LD
Sci Immunol; 2016 Dec; 1(6):. PubMed ID: 28783691
[TBL] [Abstract][Full Text] [Related]
7. Determination of
Janssen AWF; Jansen Holleboom W; Rijkers D; Louisse J; Hoekstra SA; Schild S; Vrolijk MF; Hoogenboom RLAP; Beekmann K
Front Toxicol; 2024; 6():1347965. PubMed ID: 38549690
[TBL] [Abstract][Full Text] [Related]
8. Diverse and reprogrammable mechanisms of malignant cell transformation in lymphocytes: pathogenetic insights and translational implications.
Wasik MA; Kim PM; Nejati R
Front Oncol; 2024; 14():1383741. PubMed ID: 38638855
[TBL] [Abstract][Full Text] [Related]
9. RAG genomic variation causes autoimmune diseases through specific structure-based mechanisms of enzyme dysregulation.
Haque N; Kawai T; Ratnasinghe BD; Wagenknecht JB; Urrutia R; Notarangelo LD; Zimmermann MT
iScience; 2023 Oct; 26(10):108040. PubMed ID: 37854700
[TBL] [Abstract][Full Text] [Related]
10. Cell Reprogramming and Differentiation Utilizing Messenger RNA for Regenerative Medicine.
Inagaki M
J Dev Biol; 2023 Dec; 12(1):. PubMed ID: 38535481
[TBL] [Abstract][Full Text] [Related]
11. Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.
Ogana HA; Hurwitz S; Hsieh CL; Geng H; Müschen M; Bhojwani D; Wolf MA; Larocque J; Lieber MR; Kim YM
Front Cell Dev Biol; 2023; 11():1134121. PubMed ID: 37082620
[TBL] [Abstract][Full Text] [Related]
12. Cutting Edge: TCR-β Selection Is Required at the CD4
Chen ELY; Brauer PM; Martinez EC; Huang X; Yu N; Anderson MK; Li Y; Zúñiga-Pflücker JC
J Immunol; 2021 May; 206(10):2271-2276. PubMed ID: 33941655
[TBL] [Abstract][Full Text] [Related]
13. The ESC: The Dangerous By-Product of V(D)J Recombination.
Smith AL; Scott JNF; Boyes J
Front Immunol; 2019; 10():1572. PubMed ID: 31333681
[TBL] [Abstract][Full Text] [Related]
14. Cut-and-Run: A Distinct Mechanism by which V(D)J Recombination Causes Genome Instability.
Kirkham CM; Scott JNF; Wang X; Smith AL; Kupinski AP; Ford AM; Westhead DR; Stockley PG; Tuma R; Boyes J
Mol Cell; 2019 May; 74(3):584-597.e9. PubMed ID: 30905508
[TBL] [Abstract][Full Text] [Related]
15. Expression of HIV-1 matrix protein p17 and association with B-cell lymphoma in HIV-1 transgenic mice.
Carroll VA; Lafferty MK; Marchionni L; Bryant JL; Gallo RC; Garzino-Demo A
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13168-13173. PubMed ID: 27799525
[TBL] [Abstract][Full Text] [Related]
16. A biochemically defined system for coding joint formation in V(D)J recombination.
Lu H; Shimazaki N; Raval P; Gu J; Watanabe G; Schwarz K; Swanson PC; Lieber MR
Mol Cell; 2008 Aug; 31(4):485-497. PubMed ID: 18722175
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2.
Srinivas SK; Sixbey JW
J Virol; 1995 Dec; 69(12):8155-8. PubMed ID: 7494341
[TBL] [Abstract][Full Text] [Related]
18. Expression of human recombination activating genes (RAG1 and RAG2) in neoplastic lymphoid cells: correlation with cell differentiation and antigen receptor expression.
Bories JC; Cayuela JM; Loiseau P; Sigaux F
Blood; 1991 Oct; 78(8):2053-61. PubMed ID: 1832998
[TBL] [Abstract][Full Text] [Related]
19. Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment.
Asnafi V; Beldjord K; Boulanger E; Comba B; Le Tutour P; Estienne MH; Davi F; Landman-Parker J; Quartier P; Buzyn A; Delabesse E; Valensi F; Macintyre E
Blood; 2003 Apr; 101(7):2693-703. PubMed ID: 12446444
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
